Literature DB >> 15931347

Tests of liver injury.

Kenneth A Musana1, Steven H Yale, Ahmad S Abdulkarim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15931347      PMCID： PMC1069083          DOI： 10.3121/cmr.2.2.129

Source DB:  PubMed          Journal:  Clin Med Res        ISSN： 1539-4182


× No keyword cloud information.
  7 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

Review 2.  AGA technical review on the evaluation of liver chemistry tests.

Authors:  Richard M Green; Steven Flamm
Journal:  Gastroenterology       Date:  2002-10       Impact factor: 22.682

Review 3.  Evaluation of abnormal liver function tests.

Authors:  R H Moseley
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

Review 4.  Diagnosis of hepatitis C.

Authors:  A S Lok; N T Gunaratnam
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

5.  Serum alanine aminotransferase (ALT) elevation in asymptomatic US Air Force basic trainee blood donors.

Authors:  L W Kundrotas; D J Clement
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

6.  The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients.

Authors:  U L Mathiesen; L E Franzén; A Frydén; U Foberg; G Bodemar
Journal:  Scand J Gastroenterol       Date:  1999-01       Impact factor: 2.423

Review 7.  Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327
  7 in total
  13 in total

1.  Testing for hepatitis C virus infection.

Authors:  Josephine Birungi
Journal:  Clin Med Res       Date:  2005-08

2.  Sensitivity and specificity of tests of liver injury.

Authors:  Vinoo Cameron
Journal:  Clin Med Res       Date:  2004-11

3.  Runt-related transcription factor 3 is involved in the altered phenotype and function in ThPok-deficient invariant natural killer T cells.

Authors:  Xia Liu; Shengxia Yin; Wenqiang Cao; Wei Fan; Lei Yu; Li Yin; Lie Wang; Jianli Wang
Journal:  Cell Mol Immunol       Date:  2014-02-24       Impact factor: 11.530

4.  Alterations in the rat serum proteome during liver injury from acetaminophen exposure.

Authors:  B Alex Merrick; Maribel E Bruno; Jennifer H Madenspacher; Barbara A Wetmore; Julie Foley; Rembert Pieper; Ming Zhao; Anthony J Makusky; Andrew M McGrath; Jeff X Zhou; John Taylor; Kenneth B Tomer
Journal:  J Pharmacol Exp Ther       Date:  2006-05-10       Impact factor: 4.030

5.  Serum Level of Alanine- and Aspartate-Aminotransferase Levels in Newborns in India.

Authors:  Nanda Chhavi; Sachi Ojha; Ashish Awasthi; Amit Goel
Journal:  J Clin Exp Hepatol       Date:  2021-09-23

6.  Factors associated with increased incidence of severe toxicities following yttrium-90 resin microspheres in the treatment of hepatic malignancies.

Authors:  John D Roberson Ii; Andrew M McDonald; Craig J Baden; Chee Paul Lin; Rojymon Jacob; Omer L Burnett Iii
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

Review 7.  Persistent hypertransaminasemia in asymptomatic children: a stepwise approach.

Authors:  Pietro Vajro; Sergio Maddaluno; Claudio Veropalumbo
Journal:  World J Gastroenterol       Date:  2013-05-14       Impact factor: 5.742

Review 8.  Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy.

Authors:  Anastasia Asimakopoulou; Sabine Weiskirchen; Ralf Weiskirchen
Journal:  Front Physiol       Date:  2016-09-27       Impact factor: 4.566

9.  New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology.

Authors:  Svetlana Gorodin; Serhat Unal; Youchun Wang; Mikhail I Mikhaylov; Ludmila Bigbulatova; Tamar Jehuda-Cohen
Journal:  ScientificWorldJournal       Date:  2013-02-14

10.  Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.

Authors:  Harri M Itkonen; Saurabh S Gorad; Damien Y Duveau; Sara E S Martin; Anna Barkovskaya; Tone F Bathen; Siver A Moestue; Ian G Mills
Journal:  Oncotarget       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.